









Markets
/
Stocks
/
nasdaq-cv
/

CapsoVision Inc

7.510USD

-0.020-0.27%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

348.04MMarket Cap

LossP/E TTM



CapsoVision Inc

7.510

-0.020-0.27%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of CapsoVision Inc

Currency: USD Updated: 2026-03-27

Key Insights

CapsoVision Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 106 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very low.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 12.50.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

CapsoVision Inc's Score

Industry at a Glance

Industry Ranking

106 / 208

Overall Ranking

251 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

CapsoVision Inc Highlights

StrengthsRisks

CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 38.97% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 13.55M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 13.55M.

Fairly Valued

The company’s latest PE is -7.28, at a medium 3-year percentile range.

Held by The Vanguard

Star Investor The Vanguard holds 134.18K shares of this stock.

Analyst Rating

Based on 2 analysts

Buy

Current Rating

10.500

Target Price

+39.44%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of CapsoVision Inc is 6.76, ranking 115 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is low.

Score

Industry at a Glance

Previous score

6.76

Change



Financials

9.83

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.17

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

2.84

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.70

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.27

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

CapsoVision Inc's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of CapsoVision Inc is 7.44, ranking 85 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -7.28, which is -44.67% below the recent high of -4.03 and -76.54% above the recent low of -12.86.

Score

Industry at a Glance

Previous score

7.44

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 106/208

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of CapsoVision Inc is 8.00, ranking 61 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 6.00, with a high of 7.00 and a low of 5.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 2 analysts

Buy

Current Rating

10.500

Target Price

+39.44%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

CapsoVision Inc

Intuitive Surgical Inc

ISRG

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of CapsoVision Inc is 6.60, ranking 102 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 9.54 and the support level at 5.11, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.62

Change

-0.02

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.548

Buy

RSI(14)

62.830

Neutral

STOCH(KDJ)(9,3,3)

65.036

Neutral

ATR(14)

0.952

High Vlolatility

CCI(14)

44.574

Neutral

Williams %R

40.340

Buy

TRIX(12,20)

1.751

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

8.036

Sell

MA10

6.935

Buy

MA20

6.095

Buy

MA50

5.604

Buy

MA100

6.793

Buy

MA200

5.671

Buy

Institutional Confidence

Currency: USD Updated: 2026-03-27

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Harari Eliyahou Et Al

4.31M

Ching-Hang (Shen)

3.99M

+2.07%

Kioxia Corporation

3.45M

CID Greater China Venture Capital Fund III, L.P.

3.13M

-0.00%

Shih-Chang (Stephen Wu)

2.36M

Wang (Kang-Huai)

1.10M

Harari (Michele)

576.80K

+0.50%

BlackRock Institutional Trust Company, N.A.

53.01K

Geode Capital Management, L.L.C.

115.03K

+361.98%

The Vanguard Group, Inc.

Star Investors

69.58K

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of CapsoVision Inc is 1.55, ranking 184 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.